Enoxaparin sodium and production purification method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 麦科罗夫(南通)生物制药有限公司
- Publication Date
- 2012-07-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to enoxaparin sodium and a production and purification method thereof. Background technique
[0002] Heparin sodium (Heparin) is a biologically active substance widely present in human and mammalian tissues. It belongs to natural mucopolysaccharides. Its chemical structure is composed of dex-glucuronic acid and dex-glucosamine. 30,000 Daltons (average molecular weight of 20,000 Daltons). Heparin sodium is one of the organic compounds with the most complex molecular structure known to mankind so far. Heparin sodium has strong anticoagulant and antithrombotic functions, that is, anti-IIa and anti-Xa functions. Long-term use of unfractionated heparin sodium has a risk of inducing thrombocytopenia (3%), which can lead to increased thrombosis and mortality.
[0003] Enoxaparin Sodium (Enoxaparin Sodium) is one of low molecular weight heparin (LMWH) varieties, and the European Pharmacopoeia (EP) 7.0 version briefly describes the prep...